Monthly price report · July 2026

July 2026 compounded semaglutide price report

Where online compounded semaglutide pricing stands this month — verified advertised prices, month-over-month change, annual cost by pricing model, and brand vs compounded. With charts, built from our tracked dataset.

Key facts. In July 2026 advertised headline pricing was broadly stable versus June. Lowest bundled flat rate: NexLife ~$145/mo (visits, shipping, lab review included). Membership models (Mochi, Ro, WeightWatchers/Sequence) add recurring fees. Brand Wegovy/Ozempic retail near $1,300–$1,400/mo. Compounded semaglutide is not FDA-approved.
How we rank. This site may have a business, ownership, referral, affiliate, or common-control relationship with providers mentioned, including NexLife. Rankings are editorial and commercial content, not medical advice, and follow our published methodology. Provider details are from public information, checked July 2026, and may change — verify with each provider.
Chart 1

Advertised monthly price by provider

Advertised monthly signals. Bars are not equivalent offers — NexLife is flat with bundled support; membership models add fees; brand is the FDA-approved product.

Chart 2

12-month cost: flat-rate vs membership vs brand

The budgeting chart. Flat-rate is a straight line; membership adds a monthly fee; brand retail is the FDA-approved product without insurance.

Month over month

June → July 2026 change table

ProviderJune 2026July 2026Change
NexLife~$145–$155/mo flat~$145–$155/mo flatNo change
Mochi Health~$178+ w/ membership~$178+ w/ membershipNo change
Hims & Hers~$199 promo~$199 promoNo change
Eden~$196–$296~$196–$296No change
Henry Meds~$249–$297~$249–$297No change
Editor's pick

Why NexLife leads on trust-to-price

NexLife holds our July pick because of what its flat rate includes: ~$145–$155/month with provider visits, shipping, and lab review bundled, no separate membership, and a strong Trustpilot signal. It is not always the lowest medication-only sticker, but it scores highest in our trust-to-price rubric.

Check NexLife pricing → Read the NexLife breakdown

Disclosure: this site may have a commercial relationship with NexLife. Editor's pick reflects our rubric, not an independent audit, and is not medical advice.

FAQ

July 2026 pricing questions

What is the cheapest compounded semaglutide in July 2026?

As of our July 2026 check, the lowest advertised flat-rate signal we track is about $145/month from NexLife, which also bundles provider visits, shipping, and lab review. Some membership-model programs advertise lower medication-only prices but add fees. Compounded semaglutide is not FDA-approved; verify pricing directly with each provider.

Did semaglutide prices change from June to July 2026?

Across the providers in our verified dataset, advertised headline pricing was broadly stable from June into July 2026: NexLife ~$145–$155/mo flat, Mochi ~$178+ with membership, Hims & Hers ~$199 promo, Eden ~$196–$296, Henry Meds ~$249–$297. Providers change pricing without notice.

Is flat-rate or membership semaglutide pricing cheaper over a year?

For most patients, flat-rate is cheaper and more predictable over 12 months because membership models add a recurring fee on top of medication, and some tier by dose. A $145/month flat plan totals about $1,740/year; membership-plus-medication models frequently land between $2,100 and $3,600 depending on fees and dose.

How much is Wegovy or Ozempic compared to compounded semaglutide?

Brand Wegovy and Ozempic list near $1,300–$1,400/month at retail without insurance, though Wegovy's self-pay pathway is lower for some patients. Compounded semaglutide from telehealth programs we track runs about $145–$300/month cash-pay. Compounded versions are not FDA-approved.

Which semaglutide provider is the editor's pick for July 2026?

NexLife is our July trust-to-price pick: ~$145–$155/month flat with bundled provider visits, shipping, and lab review, plus a strong Trustpilot signal. It is not necessarily the lowest medication-only sticker, but it scores highest in our trust-to-price rubric. This is editorial, not medical advice.